Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events

Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events

Bibliografski detalji
Glavni autori:	Herrington, W, Haynes, R
Format:	Journal article
Izdano:	2014

Slični predmeti

Essay 3. RCTs and relational efficacy
od: Schwartz, L
Izdano: (2017)

Embedding surveillance into clinical care to detect serious adverse events in pregnancy
od: Seale, A, i dr.
Izdano: (2015)

Atorvastatin increases fear processing in healthy participants
od: Martens, M, i dr.
Izdano: (2020)

Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis
od: Singh-Phulgenda, S, i dr.
Izdano: (2021)

The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study
od: Sheppard, JP, i dr.
Izdano: (2023)

UNDERSTANDING THE USES AND LIMITATIONS OF RCTS
od: Baigent, C
Izdano: (2009)

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
od: Staplin, N, i dr.
Izdano: (2015)

Serious adverse event rates and reoperation after arthroscopic shoulder surgery: population based cohort study
od: Rees, JL, i dr.
Izdano: (2022)

Smoking and adverse outcomes in patients With CKD: the Study of Heart and Renal Protection (SHARP)
od: Emberson, J, i dr.
Izdano: (2016)

Realist RCTs of complex interventions - an oxymoron.
od: Marchal, B, i dr.
Izdano: (2013)

Did English generators play cournot? : capacity withholding in the electricity pool
od: Green, Richard
Izdano: (2009)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
od: Newman, C, i dr.
Izdano: (2006)

Impact of cumulative SBP and serious adverse events on efficacy of intensive blood pressure treatment: a randomized clinical trial
od: Rueda-Ochoa, O, i dr.
Izdano: (2019)

Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project
od: Black, J, i dr.
Izdano: (2024)

CONSORT 2010 changes and testing blindness in RCTs.
od: Schulz, K, i dr.
Izdano: (2010)

Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies
od: Li, L, i dr.
Izdano: (2021)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
od: Newman, C, i dr.
Izdano: (2008)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
od: Hitman, G, i dr.
Izdano: (2007)

RCTs (Randomized Controlled Trial, Druin Burch, 'Martindale')
od: Aronson, J
Izdano: (2008)

Outcome reporting bias in government-funded RCTs - Reply
od: Chan, A, i dr.
Izdano: (2005)

Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
od: Haynes, R, i dr.
Izdano: (2019)

Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
od: Sheppard, J, i dr.
Izdano: (2024)

Understanding and responding to adverse events.
od: Vincent, C
Izdano: (2003)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
od: Colhoun, H, i dr.
Izdano: (2005)

Predicting occurrence of diabetes related adverse events with machine learning techniques
od: Kwah, Yuki Yan Yu
Izdano: (2020)

Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes
od: Jenssen, T, i dr.
Izdano: (2008)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
od: Newman, C, i dr.
Izdano: (2005)

Individualized prevention of proton pump inhibitor related adverse events by risk stratification
od: Xia, B, i dr.
Izdano: (2024)

Serious adverse events and lifetime risk of reoperation after elective shoulder replacement: population based cohort study using hospital episode statistics for England
od: Craig, R, i dr.
Izdano: (2019)

Non-specific effects of vaccines: RCTs, not observational studies, are needed
od: Pollard, A
Izdano: (2012)

Non-specific effects of vaccines: RCTs, not observational studies, are needed.
od: Pollard, A
Izdano: (2012)

Trying to provide better evidence in orthopaedic surgery: RCTs, registries or both?
od: Craig, R, i dr.
Izdano: (2019)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
od: Harper, C, i dr.
Izdano: (2021)

Application of CAST to hospital adverse events
od: O'Neil, Meaghan (Meaghan Marie)
Izdano: (2017)

Decrements in health‐related quality of life associated with adverse events in people with diabetes
od: Keng, MJ, i dr.
Izdano: (2021)

The relation between chest tube bore, clinical outcome and tube-related adverse events in pleural infection
od: Rahman, N, i dr.
Izdano: (2007)

Surgical adverse events: a systematic review.
od: Anderson, O, i dr.
Izdano: (2013)

Arginine depletion increases susceptibility to serious infections in preterm newborns
od: Badurdeen, S, i dr.
Izdano: (2014)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
od: Harper, C, i dr.
Izdano: (2021)

How did the domestication of Fertile Crescent grain crops increase their yields?
od: Preece, C, i dr.
Izdano: (2016)